Expanding use of pneumococcal conjugate vaccines could save 700,000 children, modeling study finds

Utilizing pneumococcal conjugate vaccines (PCVs) could save almost 700,000 children’s lives between the time of their introduction to the year 2030, according to a new modeling study. This would be equivalent to the average number of babies born in the UK each year.

This post was originally published on this site

Lawyers Lookup - LawyersLookup.ca